Ya-chuan Liu

Title: Innovations by Ya-chuan Liu

Introduction

Ya-chuan Liu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody fusion proteins. With a total of 2 patents, his work focuses on innovative solutions for drug delivery and cancer treatment.

Latest Patents

Ya-chuan Liu's latest patents include "Desmoglein 2 antibody fusion proteins for drug delivery." This invention relates to antibody fusion proteins designed for intra-cellular and intra-nucleus drug delivery. The fusion protein serves as a peptide penetration system that specifically binds to various targets, facilitating the delivery of effector peptides across biological barriers. Another notable patent is "Dsg2 monoclonal antibody and the applications thereof." This invention provides antibodies against the antigen containing the Dsg2 extracellular domain 2, along with methods for using these antibodies in the treatment or prevention of cancer.

Career Highlights

Ya-chuan Liu is currently associated with Asclepiumm Taiwan Co., Ltd., where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential applications in medicine.

Collaborations

Ya-chuan Liu collaborates with notable colleagues, including Po-hao Chang and Min-che Chen, who contribute to his research endeavors.

Conclusion

Ya-chuan Liu's innovative work in antibody fusion proteins exemplifies the potential of biotechnology in addressing critical health challenges. His contributions are paving the way for advancements in drug delivery and cancer treatment.